Radiation therapy in stage I-II uterine sarcoma

Sarcoma is one of the most aggressive and rare tumors, and its incidence makes up 3 to 9 % of all tumors of the uterus. Operative intervention is a standard treatment for such patients, and in recent years it has not undergone any significant changes that could significantly improve long-term results, and in particular reduce the incidence of local recurrence. Today there is no convincing evidence on the positive effect of any adjuvant therapy, including radiation treatment. At the same time, radiotherapy reduces the incidence of locoregional relapses, but still does not affect the incidence of distant metastases. This review studies the use of radiotherapy with different histotypes of sarcoma, the interdependence between postoperative radiotherapy in patients with sarcoma, and improved locoregional control, which in turn correlates with the presented data of our own research.